UniQuest,
5
9M
5
0.42
- Areas of investment
Summary
UniQuest, appeared to be the Corporate Investor, which was created in 2011.
Among the most successful fund investment fields, there are Wearables, Medical Device. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline LifeSignals
Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2016.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the UniQuest,, startups are often financed by XSeed Capital, Reddy Capital, Seraph Group. The meaningful sponsors for the fund in investment in the same round are muru-D, XSeed Capital, Seraph Group.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Rounds per year
- 0.42
- Investments by industry
- Wearables (2)
- Health Care (2)
- Medical Device (2)
- Electronics (2)
- Biotechnology (1) Show 14 more
- Investments by region
-
- Australia (2)
- United States (2)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 292K
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Vaxxas | 05 Dec 2022 | Biotechnology, Health Care, Medical Device | Late Stage Venture | 24M | New South Wales, Sydney, Australia |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.